Aeolus Pharmaceuticals, Inc.

Aeolus Pharmaceuticals Inc. (Aeolus) is a biopharmaceutical company engaged in developing a new class of catalytic antioxidant compounds. These compounds are used for disease and disorders of the central nervous system, respiratory system, autoimmune system and oncology. The company has developed 200 proprietary catalytic antioxidant compounds from its inception. It is focusing on the side effects of mustard gas exposure, cancer radiation therapy and amyotrophic lateral sclerosis. The lead product candidate of the company is AEOL 10150. The company is headquartered in California, the US.

Street: 
Suite 150
City: 
Mission Viejo
Postcode: 
92691
Federal State : 
United States
WebSite: 
www.aeoluspharma.com
Fax: 
1-949-4819829

Company Index Score

Current Index Score Historical Index Score
  • Aeolus Pharmaceuticals, Inc. currently scores 50 % in the index.
  • Aeolus Pharmaceuticals, Inc. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Aeolus Pharmaceuticals, Inc. is currently ranked 3 out of 10785 companies. This is in the top 0.028 % percent of Energy companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets